An Evil Backstage Manipulator: Psychological Factors Correlated with Health-Related Quality of Life in Chinese Patients with Crohn’s Disease
Table 2
Demographics and clinical characteristics in patients with Crohn’s disease.
Quiescent CD (CDAI* ≤ 150 points)
Active CD (CDAI > 150 points)
P
Number of patients
40
40
—
Male (%)
30 (75.0)
31 (77.5)
ns
Age (years)
0.015
Education (years)
ns
Smoking history
ns
Never
27
24
Past smoker
12
11
Current smoker
1
5
Duration of disease (years)
ns
Times of previous gastrointestinal operations
ns
0
20
17
1
13
14
2
6
3
≥3
1
6
Disease location
ns
L1 (ileal)
18
18
L2 (colonic)
8
10
L3 (ileocolonic)
14
12
+L4 (upper gastrointestinal)
2
2
Disease behavior
ns
B1 (inflammatory)
10
10
B2 (stricturing)
24
23
B3 (penetrating)
6
7
+P (perianal)
18
17
Medications&
ns
None
5
0
5-ASA#
22
26
Azathioprine
6
6
TWP%
4
6
Enteral nutrition
18
17
CDAI score
<0.001
C-reactive protein (mg/L)
<0.001
Erythrocyte sedimentation rate (mm/hour)
0.022
Platelet count (×109/L)
ns
Crohn’s disease activity score; &sum may be more than 100% as one patient may be prescribed with several medications; #5-aminosalicylic acid mainly includes sulfasalazine and mesalazine; %Tripterygium wilfordii polyglycoside; ns: not significant.
